de Boer A - Search Results

1

Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders.

Mulder J, Verjans R, Verbaanderd C, Pean E, Weemers J, Leufkens HGM, Pignatti F, de Boer A, Voest EE, Stoyanova-Beninska VV, Pasmooij AMG. Mulder J, et al. Among authors: de boer a. Front Med (Lausanne). 2021 Dec 9;8:790782. doi: 10.3389/fmed.2021.790782. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34957158 Free PMC article.

2

Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study.

Schillevoort I, de Boer A, van der Weide J, Steijns LS, Roos RA, Jansen PA, Leufkens HG. Schillevoort I, et al. Among authors: de boer a. Pharmacogenetics. 2002 Apr;12(3):235-40. doi: 10.1097/00008571-200204000-00008. Pharmacogenetics. 2002. PMID: 11927839

3

Lipid-lowering drug use and cardiovascular events after myocardial infarction.

Klungel OH, Heckbert SR, de Boer A, Leufkens HG, Sullivan SD, Fishman PA, Veenstra DL, Psaty BM. Klungel OH, et al. Among authors: de boer a. Ann Pharmacother. 2002 May;36(5):751-7. doi: 10.1345/aph.1A308. Ann Pharmacother. 2002. PMID: 11978147

4

Essential medicines are more available than other medicines around the globe.

Bazargani YT, Ewen M, de Boer A, Leufkens HG, Mantel-Teeuwisse AK. Bazargani YT, et al. Among authors: de boer a. PLoS One. 2014 Feb 12;9(2):e87576. doi: 10.1371/journal.pone.0087576. eCollection 2014. PLoS One. 2014. PMID: 24533058 Free PMC article.

5

Risk of fracture in patients with Charcot-Marie-Tooth disease.

Pouwels S, de Boer A, Leufkens HG, Weber WE, Cooper C, de Vries F. Pouwels S, et al. Among authors: de vries f, de boer a. Muscle Nerve. 2014 Dec;50(6):919-24. doi: 10.1002/mus.24240. Muscle Nerve. 2014. PMID: 24634316

6

Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.

Bazargani YT, de Boer A, Leufkens HG, Mantel-Teeuwisse AK. Bazargani YT, et al. Among authors: de boer a. PLoS One. 2014 Sep 26;9(9):e106072. doi: 10.1371/journal.pone.0106072. eCollection 2014. PLoS One. 2014. PMID: 25259517 Free PMC article.

7

Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins.

Althunian TA, de Boer A, Mantel-Teeuwisse AK, Groenwold RHH, Gispen-de Wied CC, Leufkens HGM, Klungel OH. Althunian TA, et al. Among authors: de boer a. Clin Ther. 2020 Aug;42(8):1588-1594. doi: 10.1016/j.clinthera.2020.06.004. Epub 2020 Aug 8. Clin Ther. 2020. PMID: 32782135 Free article.

8

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.

Ismail RK, Sikkes NO, Wouters MWJM, Hilarius DL, Pasmooij AMG, van den Eertwegh AJM, Aarts MJB, van den Berkmortel FWPJ, Boers-Sonderen MJ, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije BJ, van der Veldt AAM, Vreugdenhil A, van Dartel M, de Boer A. Ismail RK, et al. Among authors: de groot jwb, de boer a. Melanoma Res. 2021 Feb 1;31(1):58-66. doi: 10.1097/CMR.0000000000000707. Melanoma Res. 2021. PMID: 33351553 Free PMC article.

9

Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation.

Mulder J, van Rossum T, Mariz S, Magrelli A, de Boer A, Pasmooij AMG, Stoyanova-Beninska V. Mulder J, et al. Among authors: de boer a. Front Oncol. 2021 Dec 20;11:809035. doi: 10.3389/fonc.2021.809035. eCollection 2021. Front Oncol. 2021. PMID: 34988030 Free PMC article.

10

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.

Ismail RK, Suijkerbuijk KPM, de Boer A, van Dartel M, Hilarius DL, Pasmooij AMG, van Zeijl MCT, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Boers-Sonderen MJ, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Piersma D, van Rijn RS, van der Veldt AAM, Vreugdenhil A, Westgeest H, van den Eertwegh AJ, Wouters MWJM. Ismail RK, et al. Among authors: de groot jwb, de boer a. Melanoma Res. 2022 Dec 1;32(6):460-468. doi: 10.1097/CMR.0000000000000832. Epub 2022 Sep 5. Melanoma Res. 2022. PMID: 35703270 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,398 results

Search Page

Filters